Drug Name Rebif (interferon beta-1) Drug Class Immunosuppressant Risk minimization type Direct Healthcare Professional Communication DHPC Specialty (Theraputic area) Neurology Risk Communication on the association of Interferon Beta with the risk of thrombotic microangiopathy and nephrotic syndrome Dear Healthcare provider letter DHPC